684 related articles for article (PubMed ID: 28378615)
1. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
[TBL] [Abstract][Full Text] [Related]
2. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
Tripathi M; Dhawan V; Peng S; Kushwaha S; Batla A; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiology; 2013 Mar; 55(4):483-92. PubMed ID: 23314836
[TBL] [Abstract][Full Text] [Related]
4. FDG PET in the differential diagnosis of parkinsonian disorders.
Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
[TBL] [Abstract][Full Text] [Related]
5. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
Zhao P; Zhang B; Gao S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
[TBL] [Abstract][Full Text] [Related]
7. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of dual-phase
Oh M; Lee N; Kim C; Son HJ; Sung C; Oh SJ; Lee SJ; Chung SJ; Lee CS; Kim JS
Sci Rep; 2021 Jul; 11(1):14992. PubMed ID: 34294739
[TBL] [Abstract][Full Text] [Related]
9. [The clinical application value of brain
Gu Q; Chen SF; Chen KL; Huang YY; Ge JJ; Zuo CT; Cui M; Dong Q; Yu JT
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3294-3300. PubMed ID: 37926574
[No Abstract] [Full Text] [Related]
10. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
[TBL] [Abstract][Full Text] [Related]
12. Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
Tripathi M; Tang CC; Feigin A; De Lucia I; Nazem A; Dhawan V; Eidelberg D
J Nucl Med; 2016 Jan; 57(1):60-6. PubMed ID: 26449840
[TBL] [Abstract][Full Text] [Related]
13. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
Juh R; Pae CU; Lee CU; Yang D; Chung Y; Suh T; Choe B
Neurosci Res; 2005 Jul; 52(3):211-9. PubMed ID: 15927722
[TBL] [Abstract][Full Text] [Related]
14. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
[TBL] [Abstract][Full Text] [Related]
15. Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism.
Akdemir ÜÖ; Tokçaer AB; Karakuş A; Kapucu LÖ
Clin Nucl Med; 2014 Mar; 39(3):e220-6. PubMed ID: 24321825
[TBL] [Abstract][Full Text] [Related]
16. Abnormal metabolic networks in atypical parkinsonism.
Eckert T; Tang C; Ma Y; Brown N; Lin T; Frucht S; Feigin A; Eidelberg D
Mov Disord; 2008 Apr; 23(5):727-33. PubMed ID: 18186116
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
[TBL] [Abstract][Full Text] [Related]
18. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
[TBL] [Abstract][Full Text] [Related]
19. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
[TBL] [Abstract][Full Text] [Related]
20. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
